A 68-year-old man with severe community-acquired pneumonia has completed 5 days of intravenous antibiotics in the ICU and is ready for discharge. He lives alone, has limited health literacy, and no caregiver support at home. Which component of his discharge plan will most effectively reduce his risk of pneumonia relapse and hospital readmission?

A 65-year-old man is admitted to the ICU with severe pneumonia complicated by acute respiratory distress syndrome (ARDS). He requires prolonged mechanical ventilation and continuous sedation, and over the past week he has developed episodes of delirium. The critical care team is concerned about his high risk for Post-Intensive Care Syndrome (PICS), including long-term cognitive impairment. As the critical care pharmacist, which intervention should be prioritized to most effectively mitigate his risk of long-term cognitive deficits?

A 65-year-old male (80 kg, BMI 27 kg/m2) with chronic kidney disease and coagulopathy (INR 2.5) from liver dysfunction is admitted to the ICU with severe sepsis due to pneumonia. He is mechanically ventilated and receiving 0.1 mcg/kg/min norepinephrine via a right internal jugular central venous catheter. On admission, his temperature is 38.5 °C, blood pressure is 90/60 mm Hg, and heart rate is 110 bpm. Within the first 24 hours, which of the following interventions is most effective for reducing his risk of central line–associated bloodstream infection (CLABSI)?

A 58-year-old man with severe community-acquired pneumonia complicated by ARDS and septic shock is admitted to the ICU. He is intubated, lacks decision-making capacity, and has no documented advance directives. Despite 72 hours of lung-protective mechanical ventilation, broad-spectrum antibiotics, and vasopressor support, his condition continues to deteriorate with minimal signs of improvement. Given the highly invasive nature of ongoing therapies and the low likelihood of meaningful recovery, what is the MOST appropriate next step in management that aligns with patient-centered care principles?

A 62-year-old male with severe community-acquired pneumonia was admitted to the ICU on mechanical ventilation. After 5 days of meropenem and vancomycin, he is afebrile, inflammatory markers have normalized, and sputum cultures grew Streptococcus pneumoniae sensitive to ceftriaxone. He has passed a spontaneous breathing trial and ventilator settings have been gradually reduced. What is the MOST appropriate prioritized plan for de-escalating antimicrobial therapy and ventilator support?

A 45-year-old (80 kg) male patient is admitted to the ICU with septic shock secondary to pneumonia. He has received 4 L of crystalloid over 6 hours and is on norepinephrine 0.2 µg/kg/min. Laboratory results show albumin 2.0 g/dL and measured creatinine clearance 150 mL/min. He is currently receiving piperacillin/tazobactam 4.5 g intravenously every 6 hours as a 30-minute infusion. Considering this patient’s augmented renal clearance, hypoalbuminemia, and increased volume of distribution, which adjustment to the piperacillin/tazobactam regimen is most appropriate to optimize pharmacodynamic exposure?

A 62-year-old male patient in the ICU develops ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa. He is currently receiving intravenous piperacillin/tazobactam. The critical care pharmacist is tasked with optimizing antimicrobial therapy considering pharmacoeconomic principles, including drug acquisition costs, therapeutic drug monitoring requirements, and guideline-recommended treatment duration. Which antimicrobial therapy strategy should the pharmacist prioritize to balance clinical efficacy and cost-effectiveness?

A 62-year-old man is admitted to the ICU with severe community-acquired pneumonia. He is intubated, mechanically ventilated, and requires norepinephrine for septic shock. His initial therapy of ceftriaxone and azithromycin was started 72 hours ago, but he remains febrile, hypotensive, and has worsening bilateral infiltrates with a PaO₂/FiO₂ ratio of 150 and leukocytosis. His history is notable for a 7-day hospitalization for COPD exacerbation 2 months ago during which he completed a course of levofloxacin. Given his clinical deterioration and risk factors for multidrug-resistant pathogens, which antimicrobial regimen is the MOST appropriate empiric escalation?

A 72-year-old man who has been mechanically ventilated for 5 days in the ICU develops fever, purulent tracheal secretions, leukocytosis, and a new right lower lobe infiltrate on chest imaging. His history includes diabetes mellitus, chronic obstructive pulmonary disease, heart failure, and a prior stroke with residual dysphagia. Which of the following is the most important consideration when selecting his initial empiric antibiotic regimen for late-onset ventilator-associated pneumonia?

A 58-year-old woman with community-acquired pneumonia, limited financial resources, low health literacy, and no social support is being discharged after appropriate antibiotic therapy. She has had multiple readmissions due to difficulty affording and managing her medications. Which critical care pharmacist intervention should be prioritized to address the most significant social determinant of health contributing to her recurrent pneumonia?